Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Pharmacology & Therapeutics
|
August 17, 2002
The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects
Julián Romero, Isabel Lastres-Becker, Rosario de Miguel, et al.
Neuroscience Letters
|
November 23, 2013
An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure
Ainhoa Plaza-Zabala, Xuan Li, Mike Milovanovic, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 7, 2012
Influence of δ-opioid receptors in the behavioral effects of nicotine
Fernando Berrendero, Ainhoa Plaza-Zabala, Lola Galeote, et al.
Neuropharmacology
|
November 16, 2018
Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood
Rocio Saravia, Marc Ten-Blanco, Marina Julià-Hernández, et al.
Iscience
|
February 24, 2025
Long-term consequences of adolescent exposure to the synthetic cannabinoid AB-FUBINACA in male and female mice
Cristina Izquierdo-Luengo, María Ponce-Renilla, Marc Ten-Blanco, et al.
Translational Psychiatry
|
June 10, 2025
Exploring individual differences in fear extinction in male and female mice: insights from HPA axis, microbiota, and transcriptomics
Marc Ten-Blanco, María Ponce-Renilla, Inmaculada Pereda-Pérez, et al.
Journal of Neurochemistry
|
December 24, 2009
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant
Elena Martín-García, Aurelijus Burokas, Miquel Martín, et al.
Synapse (New York, N.Y.)
|
February 14, 2002
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease
Isabel Lastres-Becker, Henrik H Hansen, Fernando Berrendero, et al.
Biological Psychiatry
|
October 15, 2016
CB<sub>1</sub> Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal
Rocio Saravia, África Flores, Ainhoa Plaza-Zabala, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 28, 2022
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
Marc Ten-Blanco, África Flores, Inmaculada Pereda-Pérez, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Pharmacology & Therapeutics
|
August 17, 2002
The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects
Julián Romero, Isabel Lastres-Becker, Rosario de Miguel, et al.
Neuroscience Letters
|
November 23, 2013
An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure
Ainhoa Plaza-Zabala, Xuan Li, Mike Milovanovic, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 7, 2012
Influence of δ-opioid receptors in the behavioral effects of nicotine
Fernando Berrendero, Ainhoa Plaza-Zabala, Lola Galeote, et al.
Neuropharmacology
|
November 16, 2018
Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood
Rocio Saravia, Marc Ten-Blanco, Marina Julià-Hernández, et al.
Iscience
|
February 24, 2025
Long-term consequences of adolescent exposure to the synthetic cannabinoid AB-FUBINACA in male and female mice
Cristina Izquierdo-Luengo, María Ponce-Renilla, Marc Ten-Blanco, et al.
Translational Psychiatry
|
June 10, 2025
Exploring individual differences in fear extinction in male and female mice: insights from HPA axis, microbiota, and transcriptomics
Marc Ten-Blanco, María Ponce-Renilla, Inmaculada Pereda-Pérez, et al.
Journal of Neurochemistry
|
December 24, 2009
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant
Elena Martín-García, Aurelijus Burokas, Miquel Martín, et al.
Synapse (New York, N.Y.)
|
February 14, 2002
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease
Isabel Lastres-Becker, Henrik H Hansen, Fernando Berrendero, et al.
Biological Psychiatry
|
October 15, 2016
CB<sub>1</sub> Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal
Rocio Saravia, África Flores, Ainhoa Plaza-Zabala, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 28, 2022
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
Marc Ten-Blanco, África Flores, Inmaculada Pereda-Pérez, et al.
Page
of 6